The following table shows the list of Horizon 2020 projects developed by "CSL BEHRING GMBH". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | PREFER | H2020-EU.3.1.7. | participant | 0.00 | 2016-10-01 | 645 |
2 | WEB-RADR 2 | H2020-EU.3.1.7. | participant | 0.00 | 2018-09-01 | 296 |
totale | 0.00 |
This organization collaborated with partners in 12 countries.
Within the project PREFER this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | SPM | STEINBEISSER PROJECT MANAGEMENT UG (HAFTUNGSBESCHRANKT) (PRC) |
participant | UK | MDUK | MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND (OTH) |
participant | BE | MB | MINDBYTES (PRC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | UK | IAPO | INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS (OTH) |
participant | UK | Amgen | AMGEN LIMITED (PRC) |
participant | BE | KCE | FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG (REC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | US | MSD | MERCK SHARP & DOHME CORP (PRC) |
participant | BE | ECPC | EUROPEAN CANCER PATIENT COALITION (OTH) |
participant | IT | ITB | "INSTITUTO TUMORI ""GIOVANNI PAOLO II""" (REC) |
participant | NL | ASTELLAS | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
participant | LU | EPF | FORUM EUROPEEN DES PATIENTS (FPE) (OTH) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | CH | NVS | NOVARTIS PHARMA AG (PRC) |
participant | CH | Actelion | ACTELION PHARMACEUTICALS LTD (PRC) |
participant | NL | ERASMUS | ERASMUS UNIVERSITEIT ROTTERDAM (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | UK | UoB | THE UNIVERSITY OF BIRMINGHAM (HES) |
participant | NL | UMCU | UNIVERSITAIR MEDISCH CENTRUM UTRECHT (HES) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | IT | IEO | ISTITUTO EUROPEO DI ONCOLOGIA SRL (PRC) |
coordinator | SE | UU | UPPSALA UNIVERSITET (HES) |
participant | UK | UNEW | UNIVERSITY OF NEWCASTLE UPON TYNE (HES) |
participant | NL | EMC | ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (HES) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project WEB-RADR 2 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | SNOMED | INTERNATIONAL HEALTH TERMINOLOGY STANDARDS DEVELOPMENT ORGANISATION (OTH) |
participant | CH | ICH | THE INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE (OTH) |
participant | DK | DKMA | LAEGEMIDDELSTYRELSEN (PUB) |
coordinator | UK | MHRA | MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY (PUB) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | NL | LAREB | STICHTING LAREB (REC) |
participant | SE | UMC | Stiftelsen WHO Collaborating Centre for International Drug Monitoring (REC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | ES | AEMPS | AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS (PUB) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |